Metraipolis › archive › dc_a18e4e3ebe80

HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design — Europe PMC PMID:42807817

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42807817
DOI
10.3389/fimmu.2026.1953030
License (as archived)
solo-consultazione
Archived
2026-10-08T16:06:42.517Z
SHA-256 of the archived text
4f081661b28686d15c38df5a8b603e0159701b3db5d55d7dcb30fecbc3ad462a
Stable URL of this page
https://metraipolis.com/documento/dc_a18e4e3ebe80

How to cite

HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design — Europe PMC PMID:42807817 — Europe PMC (en), https://europepmc.org/article/MED/42807817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a18e4e3ebe80 (Metraipolis archive dc_a18e4e3ebe80, sha256 4f081661b28686d15c38df5a8b603e0159701b3db5d55d7dcb30fecbc3ad462a)
BibTeX
@misc{dca18e4e3ebe80,
  title = {HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design — Europe PMC PMID:42807817},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42807817},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a18e4e3ebe80; sha256 4f081661b28686d15c38df5a8b603e0159701b3db5d55d7dcb30fecbc3ad462a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42807817. Agents can read the archived copy with the MCP tool read_document.